Trial intelligence / Profile preview

Sampling Methods for Subgingival Plaque

NCT02841839Completed

Sponsor
Procter & Gamble
Start
Jun 2016
Primary completion
Jun 2016
Modality
DNA Intercalators/Alkylators
01

Overview

Open-label, single-arm trial of stannous fluoride in dental plaque and gingivitis, sponsored by Procter & Gamble. Primary endpoint: Subgingival plaque at 4 weeks. Started Jun 2016; status: completed.

02

Drugs

stannous fluoride
03

Conditions

dental plaquegingivitis

Beyond the preview

Go deeper on NCT02841839.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02841839.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call